The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia

被引:282
作者
Lee, Yvonne C. [1 ]
Nassikas, Nicholas J. [1 ]
Clauw, Daniel J. [2 ]
机构
[1] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
[2] Univ Michigan, Chron Pain & Fatigue Ctr, Sch Med, Ann Arbor, MI 48106 USA
关键词
PLACEBO-CONTROLLED TRIAL; MAJOR DEPRESSIVE DISORDER; NOXIOUS CONDITIONING STIMULATION; LOW-BACK-PAIN; DOUBLE-BLIND; KNEE OSTEOARTHRITIS; TEMPORAL SUMMATION; HEALTHY CONTROLS; SOMATOSENSORY PERCEPTION; DESCENDING CONTROL;
D O I
10.1186/ar3306
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Pain is a key component of most rheumatologic diseases. In fibromyalgia, the importance of central nervous system pain mechanisms (for example, loss of descending analgesic activity and central sensitization) is well documented. A few studies have also noted alterations in central pain processing in osteoarthritis, and some data, including the observation of widespread pain sensitivity, suggest that central pain-processing defects may alter the pain response in rheumatoid arthritis patients. When central pain is identified, different classes of analgesics (for example, serotonin-norepinephrine reuptake inhibitors, alpha(2)delta ligands) may be more effective than drugs that treat peripheral or nociceptive pain (for example, nonsteroidal anti-inflammatory drugs and opioids).
引用
收藏
页数:10
相关论文
共 87 条
[1]
Effects of treatment of peripheral pain generators in fibromyalgia patients [J].
Affaitati, Giannapia ;
Costantini, Raffaele ;
Fabrizio, Alessandra ;
Lapenna, Domenico ;
Tafuri, Emmanuele ;
Giamberardino, Maria Adele .
EUROPEAN JOURNAL OF PAIN, 2011, 15 (01) :61-69
[2]
[Anonymous], 2009, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD007076.pub2
[3]
Sensitization in patients with painful knee osteoarthritis [J].
Arendt-Nielsen, Lars ;
Nie, Hongling ;
Laursen, Mogens B. ;
Laursen, Birgitte S. ;
Madeleine, Pascal ;
Simonsen, Ole H. ;
Graven-Nielsen, Thomas .
PAIN, 2010, 149 (03) :573-581
[4]
Effect of racemic mixture and the (S+)-isomer of ketamine on temporal and spatial summation of pain [J].
ArendtNielsen, L ;
Nielsen, J ;
PetersenFelix, S ;
Schnider, TW ;
Zbinden, AM .
BRITISH JOURNAL OF ANAESTHESIA, 1996, 77 (05) :625-631
[5]
A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder [J].
Arnold, LM ;
Rosen, A ;
Pritchett, YL ;
D'Souza, DN ;
Goldstein, DJ ;
Iyengar, S ;
Wernicke, JF .
PAIN, 2005, 119 (1-3) :5-15
[6]
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder [J].
Arnold, LM ;
Lu, YL ;
Crofford, LJ ;
Wohlreich, M ;
Detke, MJ ;
Iyengar, S ;
Goldstein, DJ .
ARTHRITIS AND RHEUMATISM, 2004, 50 (09) :2974-2984
[7]
The effects of dothiepin on subjects with rheumatoid arthritis and depression [J].
Ash, G ;
Dickens, CM ;
Creed, FH ;
Jayson, MIV ;
Tomenson, B .
RHEUMATOLOGY, 1999, 38 (10) :959-967
[8]
Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study [J].
Bajaj, P ;
Bajaj, P ;
Graven-Nielsen, T ;
Arendt-Nielsen, L .
PAIN, 2001, 93 (02) :107-114
[9]
Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain [J].
Baraniuk, JN ;
Whalen, G ;
Cunningham, J ;
Clauw, DJ .
BMC MUSCULOSKELETAL DISORDERS, 2004, 5 (1)
[10]
Cellular and Molecular Mechanisms of Pain [J].
Basbaum, Allan I. ;
Bautista, Diana M. ;
Scherrer, Gregory ;
Julius, David .
CELL, 2009, 139 (02) :267-284